Lipoprotein-Associated phospholipase A2 (Lp-PLA2) (Middle Region) Peptide
Aperçu rapide pour Lipoprotein-Associated phospholipase A2 (Lp-PLA2) (Middle Region) Peptide (ABIN8104529)
Antigène
Origine
Source
Application
-
-
Protein Region
- Middle Region
-
Fonction
- PLA2G7 Peptide - middle region
-
Séquence
- EYFWGLSKFL GTHWLMGNIL RLLFGSMTTP ANWNSPLRPG EKYPLVVFSH
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti- PLA2G7 Antibody (ARP81177_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))
-
Sujet
-
Background Information: The protein encoded by this gene is a secreted enzyme that catalyzes the degradation of platelet-activating factor to biologically inactive products. Defects in this gene are a cause of platelet-activating factor acetylhydrolase deficiency. Two transcript variants encoding the same protein have been found for this gene.
Alternative Symbols: PAFAD, PAFAH, LP-PLA2, LDL-PLA2
-
Poids moléculaire
- 50 kDa
-
ID gène
- 7941
-
NCBI Accession
- NP_001161829
-
UniProt
- Q13093
Antigène
-